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Summary
Because gene-mapping efforts, using large kindreds and
parametric methods of analysis, for the neurologic dis-
order Tourette syndrome have failed, efforts are being
redirected toward association studies in young, geneti-
cally isolated populations. The availability of dense
marker maps makes it feasible to search for association
throughout the entire genome. We report the results of
such a genome scan using DNA samples from Tourette
patients and unaffected control subjects from the South
African Afrikaner population. To optimize mapping ef-
ficiency, we chose a two-step strategy. First, we screened
pools of DNA samples from both affected and control
individuals, using a dense collection of 1,167 short tan-
dem-repeat polymorphisms distributed throughout the
genome. Second, we typed those markers displaying ev-
idence of allele frequency–distribution shifts, along with
additional tightly linked markers, using DNA from each
affected and unaffected individual. To reduce false pos-
itives, we tested two independent groups of case and
control subjects. Strongest evidence for association (P
values 102 to 105) were obtained for markers within
chromosomal regions encompassing D2S1790 near the
chromosome 2 centromere, D6S477 on distal 6p,
D8S257 on 8q, D11S933 on 11q, D14S1003 on prox-
imal 14q, D20S1085 on distal 20q, and D21S1252 on
21q.
Introduction
Gilles de la Tourette syndrome (MIM 137580) is a child-
hood-onset neurologic disorder characterized by chron-
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ic, involuntary motor and vocal tics. Both twin and fam-
ily studies have indicated a high degree of heritability of
Tourette syndrome, especially when individuals with
chronic motor tics are considered affected (Patel 1996).
Concordance rates, among MZ twins, of 53% and 56%
for full-blown Tourette syndrome and 77% and 94%
for Tourette syndrome plus chronic motor tics have been
reported (Price et al. 1985; Hyde et al. 1992). Concor-
dance rates for DZ twins were 8% for Tourette syn-
drome alone and 23% for Tourette syndrome plus
chronic motor tics (Price et al. 1985). Earlier segregation
analyses indicated an autosomal dominant mode of in-
heritance, with reduced penetrance (Comings et al.
1984; Pauls and Leckman 1986; Eapen et al. 1993).
More-recent studies, however, have indicated a more
complex mode of inheritance (Hasstedt et al. 1995;
Walkup et al. 1996).
Tourette syndrome has been reported to cosegregate
with several neuropsychiatric disorders. A connection
between Tourette syndrome and obsessive-compulsive
disorder is generally accepted (Pauls et al. 1991, 1995).
Connections between Tourette syndrome and attention-
deficit disorder and between other disorders such as al-
coholism, panic attacks, and conduct disorders are con-
troversial (Comings and Comings 1988; Pauls et al.
1988; Comings 1994).
A number of large Tourette kindreds have been iden-
tified (Kurlan et al. 1986; Robertson and Trimble 1991;
McMahon et al. 1992; Hasstedt et al. 1995; Heutink et
al. 1995). Several of these kindreds have undergone
whole-genome polymorphism screening. Parametric
linkage analysis of the resulting data, under the as-
sumption of autosomal dominant inheritance, failed to
locate genes (Pakstis et al. 1991; Wilkie et al. 1992; van
de Wetering and Heutink 1993). Reasons for the failure
are unknown but may be related to the wide range of
disease severity within Tourette kindreds and/or to mis-
specification of the mode of inheritance. Associations
between three dopamine receptor genes and Tourette
syndrome have been reported (Comings et al. 1993;
No¨then et al. 1994; Grice et al. 1996), but replication
has not been achieved (Hebebrand et al. 1997).
The South African Afrikaner population arose largely
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from a small group of European, primarily Dutch, im-
migrants who began settling in Cape Town in 1652 (Tor-
rington et al. 1984; Jenkins 1990; see also Government
Communication and Information System [South Af-
rica]). By 1701, there were 1,265 Europeans at the Cape.
In the 18th century, European immigration to South Af-
rica was small. In the first half of the 19th century, par-
ticularly in the 1830s, the Afrikaners began the “Great
Treks,” a series of migrations of Europeans away from
the coastal areas, to establish farming communities in
the interior of South Africa. The small number of Eur-
opean founders of the Afrikaner population at Cape
Town, the lack of large waves of European immigration,
the Great Treks, and the relatively rapid increase in the
Afrikaner population, today at ∼3 million, all have con-
tributed to the genetic isolation and relative homoge-
neity of this population. Common mutations and/or
marker haplotypes among Afrikaners have been estab-
lished for several heritable disorders, including por-
phyria variegata, keratolytic winter erythema, hyper-
cholesterolemia, and progressive familial heart block
(Jenkins 1990, 1996; Meissner et al. 1996; Warnich et
al. 1996; Starfield et al. 1997; Groenewald et al. 1998).
We report here our efforts to map Tourette syndrome
genes, using Afrikaner patients. Starting with a whole-
genome screen of 11,000 polymorphisms, we have iden-
tified several markers that show significant differences
in allele frequency distributions between affected and
control individuals.
Subjects, Material, and Methods
Patients
Probands were selected at random, on consecutive
clinic days, from a group of existing patients at the Tour-
ette Syndrome Clinic in Pretoria, South Africa. All sub-
jects were previously identified as Tourette syndrome
patients according to criteria of the Diagnostic and Sta-
tistical Manual of Mental Disorders. Motor and vocal
tics were in the moderately severe to severe range in all
affected individuals. Tics started at !18 years, occurred
for x1 year, and were not absent for any periods 13
mo. Prior to their recruitment, probands and available
family members were evaluated personally, by two ed-
ucational psychologists, for history of tics and presence
and severity of comorbid problems. The following di-
agnostic tools were used: a self-report form designed by
the Tourette Syndrome Association Genetic Consortium
(January 1995 version), the Yale Global Tic Severity
Scale (Leckman et al. 1989), observation/examination
methods for the purpose of excluding other movement
or neurological disorders and for confirming observable
tics typical of those associated with Tourette syndrome,
and the Stony Brook Psychiatric Exclusion Checklist
(Gadow and Sprafkin 1998). English language versions
of all forms were used, as most Afrikaners, including all
patients, control subjects, and evaluators, were bilingual.
Forty Tourette syndrome patients were recruited in
the initial phase of the study (first group). For the follow-
up investigations, an additional 60 unrelated patients
agreed to participate (second group). All study subjects
spoke Afrikaans and had Afrikaner family names but
were not known to belong to any Afrikaner subgroup.
Individuals of ascertainable English descent were ex-
cluded. The first and second groups of patients (and
control subjects) were selected from the same population
base. All blood samples were coded and made anony-
mous prior to DNA isolation. Only the information on
age, sex, tics severity range, and comorbid behavioral
problems remained attached to each sample. The study
was approved by the South African Medical Research
Council Review Board.
Control Subjects
The Afrikaner individuals ( ) included in then  96
control group came from two sources: clinic personnel
and medical students. Like the patients, all control sub-
jects spoke Afrikaans and had Afrikaner family names.
Control subjects were required to complete the same self-
report form used by the patients and, in addition, were
personally evaluated by one of us (G.S.G.) for the pres-
ence of chronic motor and vocal tics. Their blood sam-
ples were coded and made anonymous prior to DNA
isolation.
Primers
Primer pairs for the detection of short tandem-repeat
polymorphisms (STRPs) were obtained from Research
Genetics. Approximately 40% of the markers were tri-
and tetranucleotide-repeat polymorphisms developed
within the Cooperative Human Linkage Center, and
nearly all of the remaining 60% were Ge´ne´thon dinu-
cleotide-repeat polymorphisms. We determined allele
sizes, using known genotypes of three CEPH individuals:
133101, 133102, and 134702. Marker spacing was de-
termined and close flanking markers selected by use of
comprehensive sex-averaged genetic maps produced by
the program CRI-MAP (Lander and Green 1987; Bro-
man et al. [in press]; see also Center for Medical
Genetics).
Sampling and DNA Pooling
Genomic DNA was isolated from individual blood
samples by standard methods (Sambrook et al. 1989).
DNA concentrations were measured by spectrophoto-
metric readings at 260 nm. Pools of template DNA were
prepared by combining 1 mg of DNA from each of 20
individuals from the first group of subjects. Two non-
overlapping pools were prepared from the affected in-
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Table 1
Chromosomal Breakdown of Markers Used in Whole-Genome
Screen
Chromosome No. of STRPs Chromosome No. of STRPs
1 96 13 41
2 91 14 48
3 60 15 31
4 65 16 35
5 78 17 41
6 69 18 47
7 66 19 24
8 67 20 32
9 39 21 14
10 43 22 17
11 44 X 52
12 67
dividuals (A1 and A2) and from the controls (C1 and
C2). The pooled DNA was diluted to a final concentra-
tion of 20 ng/ml.
PCR
Amplification of STRP markers was performed in 96-
well microtiter plates with 45 ng of either pooled DNA
or individual DNA in a 10-ml volume containing 1.5
mM MgCl2; 50 mM KCl; 10 mM Tris-HCl, pH 8.3;
0.01% (w/v) gelatin; 200 mM each dGTP, dATP, and
dTTP; 2.5 mM dCTP; 0.35 mCi a[32P]-dCTP (NEN Du
Pont; 800 Ci/mmol, 10 mCi/ml); 10 ng (∼3 pmol) each
PCR primer; and 0.3 U AmpliTaq polymerase (Boehrin-
ger Mannheim). In most cases, two markers were am-
plified simultaneously. Samples were subjected to 27 cy-
cles consisting of 30 sec at 94, 75 sec at 55, and 15
sec at 72, with a final 6 min at 72 after the last cycle.
PCR products were denatured by adding formamide and
by heating for 10 min at 95 prior to loading (1 ml) onto
vertical 6.5% polyacrylamide, 7.7 M urea DNA se-
quencing gels and running at 70 W constant power for
∼3 hours. Gels were dried on filter paper and exposed
on X-ray film.
Statistical Analysis
The following statistics were calculated to compare
affected and control allele frequency distributions for
each polymorphic marker:
“Heterogeneity” approach.—For the m alleles at a
given marker, an m by 2 contingency table was formed,
with columns corresponding to alleles in case and con-
trol individuals. Rows were ordered by increasing allele
size, and rows containing cells with expected values !1
were pooled with neighboring rows. From a x2 analysis,
empirical (two-sided) significance levels were obtained.
This approach is expected to be powerful when several
alleles occur in different frequencies in the case and con-
trol subjects.
“Single alleles” approach.—A given allele, i, was se-
lected, and all other alleles were combined into a second
category, not i. The resulting 2 by 2 table was analyzed
by use of Fisher’s exact test. The smallest (one-sided) P
value was selected (and the allele identified at which it
occurred) and adjusted for multiple comparisons by
means of a Bonferroni correction. This approach is ex-
pected to be powerful when a single allele shows asso-
ciation. One-sided P values were used because, when the
frequency of a given allele is increased in case versus
control subjects, some other allele(s) must necessarily be
decreased. When one allele is tested after another, each
allele should thus be tested only for positive association.
“t-test” approach.—Mean allele sizes for case and con-
trol subjects were compared with use of the t-test. Em-
pirical P values (two-sided) were calculated numerically.
This approach is expected to be powerful when allele
sizes are shifted in a constant direction between case and
control subjects.
Results
A first group of 40 Afrikaners clearly affected with
Tourette syndrome, along with 40 unaffected Afrikaner
controls, were recruited. DNA was pooled from two
nonoverlapping sets of 20 individuals for both affected
(A1 and A2) and control (C1 and C2) subjects. Two sets
of pools were chosen, to reduce the false-positive rate
due to slight differences in DNA concentrations and pi-
petting inaccuracies. The pooled DNA, along with stan-
dard DNA from the parents of CEPH family 1331, was
used as template in the PCR amplification of 1,167
STRPs distributed throughout the entire genome. Chro-
mosomal breakdown of the STRPs is shown in table 1.
Sex-averaged spacing between STRPs was cM3.0 3.2
(mean  SD). Ninety-five percent of the intervals be-
tween markers were !9.0 cM. Fifteen intervals were 115
cM, with the very largest at 22 cM.
Visual examination of the autoradiographic images of
pooled PCR products revealed 51 loci with consistent
differences in allele distributions between the two af-
fected and two control DNA pools. Results from six of
these loci are displayed in figure 1. Criteria for selection
of the positive loci were (1) consistency of observed dif-
ferences between affected and control subjects as deter-
mined by repeat PCR and by use of two independent
sets of control and affected pools, and (2) prevalence of
one allele in PCR products from the affected pools (in-
dicated by arrows in fig. 1). Amplification of the vast
majority of the markers resulted in indistinguishable ra-
diographic images between affected and control pools.
For a small proportion of STRPs, differences between
affected and control pools were detected for A1/C1 or
A2/C2, but not for both. This may be the consequence
of pooling DNA from only 20 individuals.
To evaluate the statistical significance of the observed
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Table 2
Loci Associated with Tourette Syndrome in First and Second Groups of Affecteds
LOCUS
FIRST GROUP OF AFFECTEDS SECOND GROUP OF AFFECTEDS
FIRST AND SECOND
GROUPS COMBINED
P (het)
P (single
alleles) P (t-test) P (het)
P (single
alleles) P (t-test) P (het)
D1S485 .02 .005 .12 .25 .24 .22 .02
D1S1665 .01 .001 .04 .12 .06 .45 .008
D2S1391 .04 .16 .41 .14 .10 .29 .03
D2S1790 .01 .04 .03 .006 .01 .86 .0006
D4S1551 .01 .02 .12 .42 .64 .34 .03
D5S666 .03 .02 .07 .19 .62 .92 .03
D6S477 .005 .06 .08 .02 .04 .41 .0009
D6S470 .0006 .02 .001 .43 .21 .13 .004
D8S1119 .03 .06 .66 .09 .05 .82 .01
D11S933 .05 .006 .75 .002 .009 .38 .0009
D12S327 .001 .10 .04 .38 .30 .63 .006
D13S788 .005 .16 .50 .56 .43 .95 .02
D20S1085 .03 .03 .65 .0005 .0004 .76 .0001
D21S1252 .00001 .006 .42 .07 .12 .36 .000008
D21S1435 .04 .05 .03 .46 .17 .24 .09
NOTE.—het  heterogeneity. P values indicate the probability of obtaining a difference as large or larger
than the one observed if there is no association between disease and marker. Values were calculated by means
of three different approaches, as described in the Subjects, Material, and Methods section.
differences in pooled PCR products, we subjected the 51
putative positive markers to individual typing, using the
same group of 40 affected and 40 control DNA samples
used for the initial genomic screen. We then compared
the resulting pairs of allele frequency distributions, using
three different statistical approaches (see the Subjects,
Material, and Methods section). For 15 of the 51 loci,
at least one of the calculated statistics showed signifi-
cance at the .05 level (table 2). For the remaining 36
markers, apparent differences between affected and con-
trol subjects were not confirmed at the .05 level.
In an attempt to reproduce these initial results, a sec-
ond group of unrelated Afrikaners (60 affected and 56
control individuals) were recruited, and their DNA was
typed individually with the 15 positive markers from the
first phase of the study. Results of the typings for the
second group are also listed in table 2. For the majority
of loci, evidence for association was not confirmed.
However, in four instances (D2S1790, D6S477,
D11S933, and D20S1085), the P values for the second
group also reached significance and were even lower
than those for the first group. For all 15 markers, P
(heterogeneity) values from the first and second groups
were then combined by summing x2 and df values (table
2). This approach of combining results was chosen as a
safeguard, to eliminate potential effects of sizing alleles
differently in the two samples. Combining results in-
creased support for association in nearly every case rel-
ative to the results from either the first or second group
of samples.
To extend these results, we typed a number of markers
closely linked to positive markers from the whole-ge-
nome scan, using both groups of samples jointly. Mark-
ers at several of these loci gave significant results, in-
cluding D2S440 adjacent to D2S1790, D8S257 and
D8S1132 close to D8S1119, D11S1377 adjacent to
D11S933, D20S468 and D20S469, both very close to
D20S1085, and GATA45C03 near D21S1252 (table 3).
Results for D11S1377 were particularly impressive. In
addition, two tightly linked markers on chromosome 14
also produced significant results (table 3). The marker
at locus D14S742 was identified in the first stage of the
study but did not quite yield P values ! 0.05 for the first
set of samples. No additional markers with significant
allele distribution differences were identified from chro-
mosomes 1, 6, 11, 12, or 13. Allele frequency distri-
butions for D11S1377 and GATA45C03 are displayed
in table 4. Note that, for each marker, more than two
common alleles were enriched in the affected subjects
compared with control subjects.
Discussion
The primary goal of this study was to identify loci
associated with Gilles de la Tourette syndrome in the
Afrikaner population, using the straightforward com-
parison of polymorphism allele frequency distributions
between severely affected probands and unaffected con-
trol subjects. We believe we have accomplished this goal
for the markers at the loci listed in tables 2 and 3.
Several groups have identified linkage disequilibrium
over broad chromosomal intervals in isolated popula-
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Table 3
Additional Loci in Selected Chromosomal Regions Associated
with Tourette Syndrome
P VALUE FOR APPROACH
LOCUS Heterogeneity Single Alleles t-test
D2S440 .002 .001 .54
D8S257 .01 .004 .74
D8S1132 .05 .10 .33
D11S1377 !106 .0005 .01
D14S742 .06 .02 .03
D14S1003 .002 .003 .00003
D20S468 .05 .06 .005
D20S469 .10 .06 .66
GATA45C03
(chromosome 21)
.0004 .004 .04
NOTE.—Results were obtained with DNA from affected and
control individuals in both first and second groups. See note for
table 2.
Figure 1 Electrophoretic profiles for markers that demonstrated consistent allele frequency distribution differences between affected and
control subjects in the first group. Segments of autoradiographs from polyacrylamide gels are displayed for six STRPs at the indicated loci. The
DNA templates used to generate the amplified DNA fragments were in the same order for each marker: standard DNA from CEPH family
parents 133101 (1) and 133102 (2), DNA pool from set 1 of unaffected control subjects (C1), DNA pool from set 1 of affected subjects (A1),
independent amplification of pools C1 and A1, DNA pool from set 2 of unaffected control subjects (C2), and DNA pool from set 2 of affected
subjects (A2). Arrows mark alleles enriched in the affected subjects. Sizes (in nucleotides) for the enriched alleles are listed on the left.
tions. Disequilibrium has readily been detected over in-
tervals ranging up to 15 cM in the Finnish population
(Peltonen and Uusitalo 1997), which is likely to be con-
siderably older than the Afrikaners. Among populations
thought to be similar in age to the Afrikaners (∼12 gen-
erations), Houwen et al. (1994) identified disequilibrium
over a 19-cM interval in patients with intrahepatic cho-
lestasis, from an isolated Netherlands fishing village, and
Puffenberger et al. (1994) found disequilibrium over at
least 10 cM among American Mennonites with Hirschs-
prung disease. Among Afrikaners, Starfield et al. (1997)
detected disequilibrium over 10 cM for keratolytic win-
ter erythema, and Groenewald et al. (1998) recently re-
ported shared haplotypes extending over ∼17 cM for
porphyria variegata. Therefore, our use of a highly in-
formative marker density of 3.0 cM gave us a good
chance of successfully detecting association among Af-
rikaner Tourette patients.
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Table 4
Allele Frequency Distributions for Two Markers with
Especially Low P Values
Mfd316 AT D11S1377
GATA45C03 (CHROMO-
SOME 21)
Allele Affected Control Allele Affected Control
124 1 0 266 0 3
128 4 0 268 62 66
130 4 7 286 1 0
132 2 6 288 10 5
134 45 20 289 6 5
136 62 42 291 32 47
138 22 52 302 1 3
140 6 19 305 4 14
142 16 5 308 15 16
144 4 9 310 28 19
146 8 6 312 14 1
148 0 6 314 3 0
318 0 1
NOTE.—Results were obtained with DNA from affected
and control individuals in both first and second groups.
The use of DNA pools in the whole-genome screen
dramatically reduced the amount of required laboratory
work. Allele frequency distributions obtained from
pooled DNA templates have been found to match, rea-
sonably well, those determined by typing individuals
(Pacek et al. 1993; Graff et al. 1997). Pooling ap-
proaches are rapidly becoming standard for themapping
of rare recessive disorders within isolated populations
(Sheffield et al. 1994; Peltonen and Uusitalo 1997). Al-
though careful scanning of the electrophoretic profiles
of the amplified fragments might be ideal (Barcellos et
al. 1997; Graff et al. 1997), visual selection of markers
with differences in allele frequency distributions is effi-
cient and has worked well for recessive disorders. The
fact that only 15 of 51 loci that appeared positive vi-
sually were confirmed by typing individuals indicated
that we were generous in our selection of candidate loci
and that, although false-negative loci cannot be com-
pletely ruled out, true-positive loci were not easily
missed.
Analysis of the amplified fragments from the DNA
pools gave no indication that a single predominant Tour-
ette gene exists among the Afrikaners or that Tourette
genes were introduced into the Afrikaner population by
a single founder. Although specific alleles at various loci
were clearly enriched in affected versus control subjects,
no single predominant alleles were found at any loci (see,
for example, table 4). Therefore, even in the isolated
Afrikaner population, several founding Tourette alleles
at several loci likely exist.
Since no one yet knows how many Tourette genes
exist, how they interact, how many Afrikaner founders
introduced Tourette genes into this population, or when
the genes might have been introduced, it is impossible
to project how many patients would be required to de-
tect association and what P values would be significant
(Kruglyak 1997). It is likewise impossible to completely
rule out subtle, undetected population differences be-
tween the patient and control groups. Nevertheless, we
feel that the P values displayed in tables 2 and 3 are
very promising. Given 1,167 markers tested, and on the
basis of the conservative Bonferroni correction for mul-
tiple testing, we would by chance expect 0.1 results sig-
nificant at the 104 level. In fact, we found four such
markers on chromosomes 11, 14, 20, and 21. Our use
of repeat PCR (testing pools A1 and C1 twice, as shown
in the figure) and separate pools of affected and control
individuals (pools A1, A2, C1, and C2), the confirmation
of results using an entire separate group of Tourette pa-
tients, and the typing of additional STRPs tightly linked
to the original positives were all designed to reduce the
possibility of false positives.
We assert that the only practical route to isolation of
Afrikaner Tourette genes is to pursue loci that give strong
evidence for association and that eventually are con-
firmed by independent studies. In this regard, Leppert
and McMahon, in their whole-genome–polymorphism
screen of unilineal branches of a very large Utah Tourette
kindred (McMahon et al. 1992), obtained some of their
strongest positive LOD scores for several markers (in-
cluding D8S257) in the exact same region of chromo-
some 8q as that identified in this study (unpublished
results). Also, Devor and Magee (in press) very recently
reported a family in which individuals with Tourette
syndrome or tics showed segregation with a balanced
chromosome 1-8 translocation [(1:8)(q21.1;q22.1)].
D8S257 is located at or very close to 8q22.1 (Bray-Ward
et al. 1996). We plan to continue our efforts among the
Afrikaners by collecting parents of affected individuals,
so that shared haplotypes can be identified, and by col-
lecting Tourette families from South African Gerefor-
meerde Church members who are themselves a subgroup
of Afrikaners (Torrington et al. 1984).
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